SMS Pharmaceuticals concludes 37th annual general meeting

SMS Pharmaceuticals Limited held its 37th annual general meeting (AGM) on Monday, September 29, 2025, at 11:00 a.m. (IST) via video conference and other audio-visual means. The meeting concluded at 12:05 p.m. (IST) and addressed several key resolutions for the financial year ended March 31, 2025.

The AGM saw the adoption of the audited standalone and consolidated financial statements, along with the reports of the board of directors and auditors. A dividend declaration on equity shares for the financial year 2024-2025 was also approved. Additionally, Trilok Potluri was re-appointed as a director by rotation.

Special business included the approval of material related party transactions with VKT Pharma Private Limited, remuneration for cost auditors for the financial year 2025-2026, and the appointment of secretarial auditors. Vamsi Krishna Potluri was re-appointed as executive director with a fixed remuneration. E-voting facilities were available from September 25, 2025, to September 28, 2025, and during the AGM, with results to be announced within two working days.